目的:为了检查干预措施的有效性,与情绪意识疗法(TREAT)重新连接的培训,以改善述情障碍,情绪失调,焦虑,抑郁症,创伤性脑损伤(TBI)参与者的愤怒和整体正面和负面影响。
方法:门诊脑损伤康复中心参与者::成年参与者,他们在复杂的轻度至重度TBI后平均11.37年,并且有升高的述情障碍(n=44),随机分为立即治疗(TREAT;n=20)或等待名单对照(WLC=24)。
方法:随机化,等待控制试验3个月随访。
方法:八次会议,结构化的培训计划,教授情绪意识和离散的情绪标签。
方法:多伦多述情障碍量表-20(TAS-20),情绪意识量表(LEAS)情绪调节量表(DERS)的难度,一般焦虑症-7(GAD-7),患者健康问卷-9(PHQ-9);状态特征愤怒表达量表(STAXI),积极和消极影响时间表(PANAS);和患者的整体变化印象(PGIC)。
结果:34名参与者按照方案完成了研究。与尚未接受干预的WLC参与者(n=16)相比,治疗参与者(n=18)的述情障碍明显减少,情绪失调,焦虑,在完成干预后大约一周内出现抑郁(所有p<0.05)。合并样本(n=34)的前/后结果显示显著改善,干预后立即和3个月,除STAXI和PANAS的积极影响子量表外的所有结果。在PGIC上,80%的人报告了整体情绪功能和生活质量的显著变化.意向治疗(ITT)分析(n=38)显示与每个方案样品相似的结果。
结论:研究结果支持治疗对慢性TBI个体的述情障碍和情绪失调的疗效。虽然焦虑和抑郁的结果也很有希望,需要更多使用注意力控制设计的研究来控制治疗期间获得的注意力.
OBJECTIVE: To examine the efficacy of an intervention, training to reconnect with emotional awareness therapy (TREAT) at improving alexithymia, emotion dysregulation, anxiety, depression, anger and global positive and negative affect in participants with traumatic brain injury (TBI).
METHODS: Outpatient brain injury rehabilitation center PARTICIPANTS: : Adult participants, who were on average 11.37 years post-complicated mild to severe TBI and also had elevated alexithymia (n=44), who were randomized to immediate treatment (TREAT; n=20) or waitlist control (WLC=24).
METHODS: Randomized, waitlist control trial with 3-month follow-up.
METHODS: Eight session, structured training program that teaches emotional awareness and discrete labeling of emotions.
METHODS: Toronto Alexithymia Scale-20 (TAS-20), Levels of Emotional Awareness Scale (LEAS), Difficulty with Emotion Regulation Scale (DERS), General Anxiety Disorder-7 (GAD-7), Patient Health Questionnaire-9 (PHQ-9); State-Trait Anger Expression Inventory (STAXI), Positive and Negative Affect Schedule (PANAS); and Patient Global Impression of Change (PGIC).
RESULTS: Thirty-four participants completed the study per protocol. Compared to WLC participants (n=16) who had not yet received the intervention, TREAT participants (n=18) had significantly less alexithymia, emotion dysregulation, anxiety, and depression (all p\'s<.05) within approximately one week of completing the intervention. Before/after results from the pooled sample (n=34) showed significant improvements, immediately and 3 months after the intervention, on all outcomes except the STAXI and the Positive Affect subscale of the PANAS. On the PGIC, a noticeable change in global emotional function and quality of life was reported by 80%. Intent-to-Treat (ITT) analyses (n=38) revealed similar results to the per protocol sample.
CONCLUSIONS: Findings support the efficacy of TREAT for reducing alexithymia and emotion dysregulation in individuals with chronic TBI. While outcomes were also promising for anxiety and depression, more research using attention-control designs are warranted to control for the attention received during treatment.